Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Smac mimetics LCL161 and GDC-0152 inhibit osteosarcoma growth and metastasis in mice.

Shekhar TM, Burvenich IJG, Harris MA, Rigopoulos A, Zanker D, Spurling A, Parker BS, Walkley CR, Scott AM, Hawkins CJ.

BMC Cancer. 2019 Sep 14;19(1):924. doi: 10.1186/s12885-019-6103-5.

2.

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.

Brockwell NK, Rautela J, Owen KL, Gearing LJ, Deb S, Harvey K, Spurling A, Zanker D, Chan CL, Cumming HE, Deng N, Zakhour JM, Duivenvoorden HM, Robinson T, Harris M, White M, Fox J, Ooi C, Kumar B, Thomson J, Potasz N, Swarbrick A, Hertzog PJ, Molloy TJ, Toole SO, Ganju V, Parker BS.

NPJ Precis Oncol. 2019 Aug 29;3:21. doi: 10.1038/s41698-019-0093-2. eCollection 2019.

3.

Advancing Racial/Ethnic and Cultural Sensitivity Among PMHNP Students Through Education, Practice, and Experience.

Boyer CJ, Rice MJ, Sorrell TR, Spurling AM.

J Am Psychiatr Nurses Assoc. 2019 Nov/Dec;25(6):487-495. doi: 10.1177/1078390318824651. Epub 2019 Jan 28.

PMID:
30688540
4.

Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers.

Duivenvoorden HM, Spurling A, O'Toole SA, Parker BS.

PLoS One. 2018 Jul 25;13(7):e0201370. doi: 10.1371/journal.pone.0201370. eCollection 2018.

5.

Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.

Duivenvoorden HM, Rautela J, Edgington-Mitchell LE, Spurling A, Greening DW, Nowell CJ, Molloy TJ, Robbins E, Brockwell NK, Lee CS, Chen M, Holliday A, Selinger CI, Hu M, Britt KL, Stroud DA, Bogyo M, Möller A, Polyak K, Sloane BF, O'Toole SA, Parker BS.

J Pathol. 2017 Dec;243(4):496-509. doi: 10.1002/path.4990. Epub 2017 Oct 31.

PMID:
29086922
6.

Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.

Brockwell NK, Owen KL, Zanker D, Spurling A, Rautela J, Duivenvoorden HM, Baschuk N, Caramia F, Loi S, Darcy PK, Lim E, Parker BS.

Cancer Immunol Res. 2017 Oct;5(10):871-884. doi: 10.1158/2326-6066.CIR-17-0150. Epub 2017 Aug 28.

7.

Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.

Konda SK, Maliki R, McGrath S, Parker BS, Robinson T, Spurling A, Cheong A, Lock P, Pigram PJ, Phillips DR, Wallace L, Day AI, Collins JG, Cutts SM.

ACS Med Chem Lett. 2017 Apr 24;8(5):538-542. doi: 10.1021/acsmedchemlett.7b00090. eCollection 2017 May 11.

8.

Wiz binds active promoters and CTCF-binding sites and is required for normal behaviour in the mouse.

Isbel L, Prokopuk L, Wu H, Daxinger L, Oey H, Spurling A, Lawther AJ, Hale MW, Whitelaw E.

Elife. 2016 Jul 13;5. pii: e15082. doi: 10.7554/eLife.15082.

9.

Hypomethylation of ERVs in the sperm of mice haploinsufficient for the histone methyltransferase Setdb1 correlates with a paternal effect on phenotype.

Daxinger L, Oey H, Isbel L, Whitelaw NC, Youngson NA, Spurling A, Vonk KK, Whitelaw E.

Sci Rep. 2016 Apr 26;6:25004. doi: 10.1038/srep25004.

10.

Trim33 Binds and Silences a Class of Young Endogenous Retroviruses in the Mouse Testis; a Novel Component of the Arms Race between Retrotransposons and the Host Genome.

Isbel L, Srivastava R, Oey H, Spurling A, Daxinger L, Puthalakath H, Whitelaw E.

PLoS Genet. 2015 Dec 1;11(12):e1005693. doi: 10.1371/journal.pgen.1005693. eCollection 2015 Dec.

11.

Risk of fall (RoF) intervention by affecting visual egocenter through gait analysis and yoked prisms.

Padula WV, Subramanian P, Spurling A, Jenness J.

NeuroRehabilitation. 2015;37(2):305-14. doi: 10.3233/NRE-151263.

PMID:
26484522
12.

Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma.

Hersey P, Coates A, Rallings M, Hall C, MacDonald M, Spurling A, Edwards A, McCarthy WH, Milton GW.

J Biol Response Mod. 1986 Jun;5(3):236-49.

PMID:
3487622
13.

Immunological effects of recombinant interferon alfa-2a in patients with disseminated melanoma.

Hersey P, MacDonald M, Hall C, Spurling A, Edwards A, Coates A, McCarthy W.

Cancer. 1986 Apr 15;57(8 Suppl):1666-74.

PMID:
3485011
14.

Effects of recombinant leukocyte interferon (rIFN-alpha A) on tumour growth and immune responses in patients with metastatic melanoma.

Hersey P, Hasic E, MacDonald M, Edwards A, Spurling A, Coates AS, Milton GW, McCarthy WH.

Br J Cancer. 1985 Jun;51(6):815-26.

15.

Inhibition of interleukin 2 production by factors released from tumor cells.

Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J, McCarthy WH.

J Immunol. 1983 Dec;131(6):2837-42.

PMID:
6605993

Supplemental Content

Loading ...
Support Center